Call us now :08071793621
Send Inquiry
Send InquiryAbiratas 250 mg Tablet
Abiratas 250 mg Tablet Specification
- Pacakaging (Quantity Per Box)
- 1 bottle containing 120 tablets
- Origin of Medicine
- Allopathic
- Salt Composition
- Abiraterone Acetate
- Drug Type
- Anti-Cancer
- Ingredients
- Abiraterone Acetate 250 mg
- Physical Form
- Tablet
- Function
- Treatment of Prostate Cancer
- Recommended For
- Men diagnosed with metastatic prostate cancer
- Dosage
- 250 mg
- Dosage Guidelines
- Take as directed by the physician typically daily with or without food
- Suitable For
- Adults
- Quantity
- 120 tablets per bottle
- Storage Instructions
- Store in a cool dry place below 30C. Keep away from direct sunlight and moisture.
About Abiratas 250 mg Tablet
Abiratas 250 mg Tablet is an anti-cancer medication containing Abiraterone Acetate 250 mg, designed for the treatment of metastatic prostate cancer in men. Each box contains 120 tablets to be taken daily as per the physicians instructions, with or without food. This allopathic medicine is suitable for adult use and should be stored below 30C in a dry place, away from sunlight and moisture.
FAQs of Abiratas 250 mg Tablet:
Q: What is Abiratas 250 mg Tablet used for?
A: Abiratas 250 mg Tablet is used in the treatment of metastatic prostate cancer in men.Q: How should Abiratas 250 mg Tablet be taken?
A: Abiratas 250 mg Tablet should be taken daily as directed by the physician, with or without food.Q: What is the dosage of Abiratas 250 mg Tablet?
A: The dosage of Abiratas 250 mg Tablet is 250 mg per tablet, with a quantity of 120 tablets per bottle.Q: What are the storage instructions for Abiratas 250 mg Tablet?
A: Abiratas 250 mg Tablet should be stored in a cool, dry place below 30C, and kept away from direct sunlight and moisture.Q: Is Abiratas 250 mg Tablet suitable for adults only?
A: Yes, Abiratas 250 mg Tablet is suitable for adults.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Anti-Cancer Category
Cassotide 50 mg Tablet
Ingredients : Bicalutamide
Storage Instructions : Store in a cool and dry place away from direct sunlight
Physical Form : Other, Tablet
Recommended For : Men diagnosed with prostate cancer
Dosage : 50 mg
Salt Composition : Bicalutamide 50 mg
Tecentriq 840 mg Injection
Ingredients : Atezolizumab 840 mg
Storage Instructions : Store in a refrigerator (2C8C) and protect from light. Do not freeze or shake.
Physical Form : Injection, Other
Recommended For : Patients with specific types of cancer such as lung cancer bladder cancer and certain types of breast cancer.
Dosage : 840 mg
Salt Composition : Atezolizumab
Jevtana Injection
Ingredients : Cabazitaxel
Storage Instructions : Store at 2C to 8C (36F to 46F) in a refrigerator. Protect from light.
Physical Form : Other, Injection
Recommended For : Patients with advanced prostate cancer
Dosage : 25 mg/m intravenously every three weeks
Salt Composition : Cabazitaxel 60 mg with polysorbate 80
Xecap 500 mg Tablet
Ingredients : Capecitabine 500 mg
Storage Instructions : Store in a cool and dry place away from direct sunlight and out of reach of children.
Physical Form : Other, Solid (Tablet)
Recommended For : Patients with colorectal and breast cancer
Dosage : 500 mg per tablet
Salt Composition : Capecitabine
Send InquiryOur Products
- Alzheimers
- Anti-Cancer
- Anti-Fungal
- Anti-Viral
- Arthritis
- Blood Disorder
- Bone Disease
- Bone Marrow Disorder
- Bowel Disease
- Critical Care
- Gynaecology
- Liver Disease
- Lung Disease
- Macular Degeneration
- Multiple Sclerosis
- Nausea
- Nephrology
- Organ Transplant
- Orthostatic Hypotension
- Osteoporsis
- Psoriasis
- Skin Disorder
- Vaccines
- Pharmaceutical Injection
- Enoxaparin Sodium Medicine
- Oral Suspension
- Pharmaceutical Tablets
- Allopathic Medicine
229, Metro Mall, Bapa Sitaram Chawk, Opp. RAF Camp, S.P. Ring Road, Vastral, Ahmedabad - 382418, Gujarat, India
Dr. Harsh M Patel
(Director)
Mobile :08071793621
Send Inquiry
Send SMS
Developed and Managed by Infocom Network Private Limited.
